First published 9/28/2026, 9:21:15 AM · Last updated 9/28/2026, 9:21:15 AM

Bioelectrical impedance-derived body composition and systemic therapy outcomes in non-small cell lung cancer

A journal article published by AME Publishing Company reports on associations between body composition measured via bioelectrical impedance and outcomes of systemic therapy for non-small cell lung cancer. The supplied excerpt includes only the publisher and publication date and provides no additional study details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The research may be relevant to clinicians and researchers studying factors linked to treatment outcomes in non-small cell lung cancer.

Sources

Bioelectrical impedance-derived body composition and systemic therapy outcomes in non-small cell lung cancer

Report an issue